{"authors": ["Tyler Cowen"], "date_download": "2024-10-12 13:52:00", "date_modify": "2024-10-12 13:52:00", "date_publish": "2024-03-07 17:00:00", "description": "The success of Novo Nordisk shows the outsized effect a single company can have on a nation.   Read more at straitstimes.com.", "filename": "opinion_ozempic-is-transforming-the-health-of-denmark-s-economy_1728741120.html", "image_url": "https://static1.straitstimes.com.sg/s3fs-public/styles/large30x20/public/articles/2024/03/07/2024-02-12T080106Z607958079RC2P34A3FCTTRTRMADP3HEALTH-OBESITY-SURGERY_0.JPG", "language": "en", "localpath": "/Users/bryansoong/news-please-repo//data/2024/10/12/straitstimes.com/opinion_ozempic-is-transforming-the-health-of-denmark-s-economy_1728741120.html", "title": "Ozempic is transforming the health of Denmark’s economy", "title_page": "Ozempic is transforming the health of Denmark’s economy | The Straits Times", "title_rss": "NULL", "source_domain": "straitstimes.com", "maintext": "From both a biomedical and economic point of view, the success of the new class of weight-loss drugs is something to behold. Not only are they a remarkable scientific achievement, but also – in the case of Ozempic and Wegovy, both made by Novo Nordisk – they are a huge boon to the Danish economy.\nThe Danish pharmaceutical industry kept Denmark from falling into a recession in 2023.", "url": "https://www.straitstimes.com/opinion/ozempic-is-transforming-the-health-of-denmark-s-economy"}